statistiche ricercatore

Continente	#
NA - Nord America	835
EU - Europa	709
AS - Asia	573
SA - Sud America	115
Continente sconosciuto - Info sul continente non disponibili	22
AF - Africa	12
OC - Oceania	3
Totale	2.269

Nazione	#
US - Stati Uniti d'America	813
RU - Federazione Russa	256
IT - Italia	198
SG - Singapore	165
CN - Cina	100
BR - Brasile	92
HK - Hong Kong	72
VN - Vietnam	66
PL - Polonia	52
IE - Irlanda	47
KR - Corea	38
TR - Turchia	34
DE - Germania	30
SE - Svezia	25
FR - Francia	24
FI - Finlandia	19
GB - Regno Unito	19
BD - Bangladesh	16
ID - Indonesia	16
IN - India	16
CA - Canada	15
AR - Argentina	11
JO - Giordania	9
TH - Thailandia	8
AT - Austria	7
PK - Pakistan	7
CH - Svizzera	6
JP - Giappone	6
PT - Portogallo	6
GR - Grecia	5
IR - Iran	5
MA - Marocco	5
MY - Malesia	5
NL - Olanda	4
AU - Australia	3
CI - Costa d'Avorio	3
CO - Colombia	3
PE - Perù	3
PY - Paraguay	3
UA - Ucraina	3
AE - Emirati Arabi Uniti	2
AL - Albania	2
ES - Italia	2
IQ - Iraq	2
MX - Messico	2
PA - Panama	2
SI - Slovenia	2
TN - Tunisia	2
TW - Taiwan	2
AZ - Azerbaigian	1
BO - Bolivia	1
CL - Cile	1
CY - Cipro	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DZ - Algeria	1
EC - Ecuador	1
JM - Giamaica	1
PH - Filippine	1
PR - Porto Rico	1
SA - Arabia Saudita	1
SV - El Salvador	1
XK - ???statistics.table.value.countryCode.XK???	1
ZA - Sudafrica	1
Totale	2.248

Nome	#
1H-NMR-based metabolomic applications in biomedical research	302
High-throughput metabolomics by 1D NMR	236
Nmr based serum metabolomics for monitoring newborn preterm calves’ health	223
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients	213
Nuclear magnetic resonance (NMR)-based metabolome profile evaluation in dairy cows with and without displaced abomasum	201
Analysis of Metabolite and Lipid Association Networks Reveals Molecular Mechanisms Associated with 3-Month Mortality and Poor Functional Outcomes in Patients with Acute Ischemic Stroke after Thrombolytic Treatment with Recombinant Tissue Plasminogen Activator	191
Nuclear Magnetic Resonance-Based Metabolomics to Predict Early and Late Adverse Outcomes in Ischemic Stroke Treated with Intravenous Thrombolysis	170
A geroscience approach for Parkinson's disease: Conceptual framework and design of PROPAG-AGEING project	163
Early downregulation of hsa-miR-144-3p in serum from drug-naïve Parkinson’s disease patients	151
Nmr based serum extracts’ metabolomics for evaluation of canine ehrlichiosis	148
Metabolite and lipoprotein profiles reveal sex-related oxidative stress imbalance in de novo drug-naive Parkinson's disease patients	138
Practical considerations for rapid and quantitative NMR-based metabolomics	133
Totale	2.269

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	81	0	4	3	3	0	6	5	8	18	3	10	21
2022/2023	198	18	43	17	4	10	29	28	13	18	1	11	6
2023/2024	167	6	6	13	13	5	14	20	24	5	21	21	19
2024/2025	735	24	79	43	113	148	129	33	38	38	43	22	25
2025/2026	897	78	99	75	117	110	32	89	51	51	45	47	103
2026/2027	23	23	0	0	0	0	0	0	0	0	0	0	0
Totale													2.269